Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Mar 21;17(11):1480-7.
doi: 10.3748/wjg.v17.i11.1480.

Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan

Takao Tsuzuki  1 , Hiroyuki Okada, Yoshiro Kawahara, Ryuta Takenaka, Junichiro Nasu, Hidehiko Ishioka, Akiko Fujiwara, Fumiya Yoshinaga, Kazuhide Yamamoto
Affiliations
Multicenter Study

Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan

Takao Tsuzuki et al. World J Gastroenterol. .

Abstract

Aim: To investigate the predictors of success in step-down of proton pump inhibitor and to assess the quality of life (QOL).

Methods: Patients who had heartburn twice a week or more were treated with 20 mg omeprazole (OPZ) once daily for 8 wk as an initial therapy (study 1). Patients whose heartburn decreased to once a week or less at the end of the initial therapy were enrolled in study 2 and treated with 10 mg OPZ as maintenance therapy for an additional 6 mo (study 2). QOL was investigated using the gastrointestinal symptom rating scale (GSRS) before initial therapy, after both 4 and 8 wk of initial therapy, and at 1, 2, 3, and 6 mo after starting maintenance therapy.

Results: In study 1, 108 patients were analyzed. Their characteristics were as follows; median age: 63 (range: 20-88) years, sex: 46 women and 62 men. The success rate of the initial therapy was 76%. In the patients with successful initial therapy, abdominal pain, indigestion and reflux GSRS scores were improved. In study 2, 83 patients were analyzed. Seventy of 83 patients completed the study 2 protocol. In the per-protocol analysis, 80% of 70 patients were successful for step-down. On multivariate analysis of baseline demographic data and clinical information, no previous treatment for gastroesophageal reflux disease (GERD) [odds ratio (OR) 0.255, 95% CI: 0.06-0.98] and a lower indigestion score in GSRS at the beginning of step-down therapy (OR 0.214, 95% CI: 0.06-0.73) were found to be the predictors of successful step-down therapy. The improved GSRS scores by initial therapy were maintained through the step-down therapy.

Conclusion: OPZ was effective for most GERD patients. However, those who have had previous treatment for GERD and experience dyspepsia before step-down require particular monitoring for relapse.

Keywords: Gastroesophageal reflux disease; Gastrointestinal symptom rating scale; Omeprazole; Proton pump inhibitor; Step-down therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of the study design. QOL: Quality of life; PPI: Proton pump inhibitor.
Figure 2
Figure 2
Gastrointestinal Symptom Rating Scale scores during the initial treatment (study 1).
Figure 3
Figure 3
Proportion of subjects without recurrent gastroesophageal reflux disease symptoms after proton pump inhibitor step-down (Study 2 per-protocol population: n = 70).
Figure 4
Figure 4
Gastrointestinal Symptom Rating Scale scores during maintenance treatment (study 2).
See this image and copyright information in PMC

References

    1. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53 Suppl 4:iv1–i24. - PMC - PubMed
    1. Kouzu T, Hishikawa E, Watanabe Y, Inoue M, Satou T. [Epidemiology of GERD in Japan] Nippon Rinsho. 2007;65:791–794. - PubMed
    1. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, Ohyama T, Noda T, Sakata H, Fujimoto K. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999;34:441–444. - PubMed
    1. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Romàn J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118:661–669. - PubMed
    1. Savarino V, Dulbecco P. Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease. Digestion. 2004;69 Suppl 1:9–16. - PubMed

Publication types

MeSH terms